SCHEMBL9016080

SCHEMBL9016080

COC(=O)C(N)CCc1c[nH]c2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.57
KMT2A Q03164 5/20 0.57
HCRTR1 O43613 1/20 0.57
CTSC P53634 1/20 0.57
MAPT P10636 5/20 0.56
LMNA P02545 3/20 0.56
TSHR P16473 2/20 0.56
BLM P54132 2/20 0.56
KDM4E B2RXH2 2/20 0.56
MPO P05164 1/20 0.56
PMP22 Q01453 1/20 0.56
HIF1A Q16665 1/20 0.56
ALDH1A1 P00352 4/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C19 P33261 2/20 0.54
PKM P14618 2/20 0.54
GAA P10253 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26371896 1.00 MEN1 (0.57) MEN1KMT2AHCRTR1CTSCMAPT
Tryptophan Methyl Ester SCHEMBL30180690 0.86 MEN1 (0.70) MEN1KMT2AHCRTR1CTSCMAPT
Tryptophan Methyl Ester SCHEMBL475267 0.86 MEN1 (0.70) MEN1KMT2AHCRTR1CTSCMAPT
Tryptophan Methyl Ester SCHEMBL1195735 0.86 MEN1 (0.70) MEN1KMT2AHCRTR1CTSCMAPT
Tryptophan Methyl Ester SCHEMBL122907 0.86 MEN1 (0.70) MEN1KMT2AHCRTR1CTSCMAPT
Tryptophan Methyl Ester SCHEMBL19161138 0.86 MEN1 (0.70) MEN1KMT2AHCRTR1CTSCMAPT
Tryptophan Methyl Ester SCHEMBL29398306 0.85 MEN1 (0.68) MEN1KMT2AHCRTR1CTSCMAPT
Tryptophan Methyl Ester SCHEMBL378071 0.85 MEN1 (0.68) MEN1KMT2AHCRTR1CTSCMAPT
Tryptophan Methyl Ester SCHEMBL378072 0.85 MEN1 (0.68) MEN1KMT2AHCRTR1CTSCMAPT
Tryptophan Methyl Ester SCHEMBL475266 0.85 MEN1 (0.68) MEN1KMT2AHCRTR1CTSCMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5508432-A TREATING GASTROINTESTINAL DISORDERS, CENTRAL NERVOUS SYSTEM DISORDERS GLAXO WELLCOME INC. (US) 1996-04-16 US disclosed
US-5380872-A Appetite suppresant, gall bladder disorders, CNS disorders GLAXO INC. (US) 1995-01-10 US disclosed